The current widespread outbreak of Zika virus (ZIKV) infection has been linked to severe clinical birth defects, particularly microcephaly, warranting urgent study of the molecular mechanisms underlying ZIKV pathogenesis. Akt-mTOR signaling is one of the key cellular pathways essential for brain development and autophagy regulation. Here, we show that ZIKV infection of human fetal neural stem cells (fNSCs) causes inhibition of the Akt-mTOR pathway, leading to defective neurogenesis and aberrant activation of autophagy. By screening the three structural proteins and seven nonstructural proteins present in ZIKV, we found that two, NS4A and NS4B, cooperatively suppress the Akt-mTOR pathway and lead to cellular dysregulation. Corresponding proteins from the closely related dengue virus do not have the same effect on neurogenesis. Thus, our study
Neurogenesis, the key process by which neurons are differentiated from neural stem cells (NSCs) or neural progenitor cells (NPCs) , is most active during prenatal development and responsible for populating the growing brain with neurons (Götz and Huttner, 2005) . Genetic defects that are associated with neurogenesis and migration often result in human developmental neurological disorders including microcephaly (Ming and Song, 2011) . A number of key cellular signaling pathways, including the PI3K-Akt-mTOR pathway, are essential for neurogenesis from NSCs, as well as for subsequent migration and maturation (Lee, 2015; Wahane et al., 2014) . Recent studies have shown that activating mutations in the PI3K-Akt-mTOR pathway may occur in brain overdevelopment syndromes, which include megalencephaly-capillary malformation and megalencephaly-polydactyly-polymicrogyriahydrocephalus (Mirzaa et al., 2013) . In contrast, mTOR inhibition in the developing brain causes microcephaly (Cloëtta et al., 2013) . Upstream to mTOR, Akt is the central signaling molecule in the PI3K pathway, and it plays critical roles in brain development as well as synaptic plasticity (Franke, 2008) . Non-functional Akt mutation leads to microcephaly in humans (Mirzaa et al., 2013) , while activating Akt mutation causes megalencephaly (Nellist et al., 2015; Rivière et al., 2012) . Expression of dominant-negative Akt also blocks neuronal production from human NSCs isolated from fetuses in vitro (Guo et al., 2013) . Hence, human pathogens, including DNA viruses, have been found to hijack the PI3K-Akt-mTOR pathway for their successful replication in mammalian cells (Buchkovich et al., 2008 ). Yet despite the common outcomes of ZIKV infection and PI3K-Akt-mTOR pathway inhibition, no causal association between the two has yet been reported.
Flaviviruses, such as DENV, Hepatitis C virus (HCV), and ZIKV, have been shown to modulate cellular autophagy to benefit their replication in host cells (Hamel et al., 2015; Heaton and Randall, 2010; Sir et al., 2012) . Macroautophagy, often referred to as autophagy, is an important catabolic process involving the formation of double-membrane vesicles, called autophagosomes, which sequester cytoplasmic damaged organelles, protein aggregates, or invading intracellular pathogens for degradation (Levine et al., 2011) . The mTOR kinase serves as a gatekeeper for autophagy induction: the activation of mTOR by Akt and MAPK signaling suppresses autophagy, and the inactivation of mTOR by AMPK and p53 signaling promotes autophagy. Autophagy is also an active cellular protective mechanism against viral infection; viruses thus try to modulate autophagy to benefit their life cycles. Certain herpesviruses suppress autophagy by their viral proteins to establish persistent infection (Liang et al., 2013 (Liang et al., , 2015 Williams and Taylor, 2012) . Interestingly, certain flaviviruses such as ZIKV and DENV have recently been reported to hijack autophagy to similarly support viral replication (Hamel et al., 2015; Heaton and Randall, 2010) . Specifically, DENV NS4A upregulates autophagy in epithelial cells (McLean et al., 2011) . However, it is currently unknown whether ZIKV infection induces autophagy through a similar mechanism to DENV. Nevertheless, understanding the molecular mechanism underlying ZIKV-induced autophagy activation in host cells may shed insight on its pathogenesis.
Recent reports using human NSCs have demonstrated the vulnerability of these cells to ZIKV infection (Garcez et al., 2016; Tang et al., 2016) , as well as the growth defects of iPSC-derived neural organoids in response to ZIKV infection (Garcez et al., 2016; . Several groups also defined the birth defects from different pregnant mouse models when exposed to ZIKV (Cugola et al., 2016; Lazear et al., 2016; Li et al., 2016; Miner et al., 2016; Rossi et al., 2016) . These suggest the direct cause of ZIKV for human microcephaly via intrauterine infection and defective neurogenesis. However, no analogous studies have been performed on native human fetal tissues or NSCs, largely due to the limited availability of fetal human tissue. Here, we utilized two primary isolates of fNSCs, recovered from second trimester human fetuses, a gestational period of great ZIKV vulnerability in human brain development, to study how ZIKV infection impairs fetal brain development. We found that ZIKV infection of human fNSCs results in the inhibition of neurosphere growth and neurogenic differentiation potential, as well as the induction of autophagy. Further screening for ZIKV proteins revealed that the cooperation of NS4A and NS4B strongly suppresses host Akt-mTOR signaling, potentially leading to the impairment of neurogenesis of human fNSCs and the upregulation of autophagy, synergistically promoting viral replication.
RESULTS

Infection of Human fNSCs with ZIKV Leads to Impaired Neurosphere Formation and Elevated Autophagy
In order to model ZIKV infection in human fNSCs (Guo et al., 2013; Keyoung et al., 2001; Wang et al., 2010) , we first infected fNSCs with three ZIKV strains (MR766, IbH30656, and H/PF/2013) at a multiplicity of infection (MOI) of 0.01. Consistent with NSCs derived from human iPSCs (Garcez et al., 2016; Tang et al., 2016) , ZIKV efficiently infected fNSCs ( Figures S1A-S1C) , and the infection of fNSCs with ZIKV MR766, IbH30656, and H/PF/ 2013 led to 4.4-, 5.2-, and 5.5-fold increases of cell death, respectively, when compared with mock treatment (Figures 1A and 1B) . At 3 days post-infection (dpi), mock-treated fNSCs in suspension culture formed neurospheres that had an average size of 81.7 μm ( Figures 1C-1E ). However, MR766-, IbH30656-, or H/PF/2013-infected fNSCs at MOI 0.01 formed fewer neurospheres with smaller average sizes of 54.3 μm, 51.2 μm, or 52.6 μm, respectively ( Figures 1D and 1E) . Immuno-histological analysis on 7 dpi neurospheres showed the presence of ZIKV E antigen within the neurospheres ( Figures 1F and S1D ). In addition, ZIKV-infected neurospheres contained more apoptotic cells than mock-infected neurospheres, as shown by in situ terminal deoxynucleotidyl transferase-mediated digoxigenin-dUTP nick-end labeling (TUNEL) ( Figure 1G ). Correlation analysis between neurosphere sizes and cell death from 30 mock-treated and 30 ZIKV-infected neurospheres showed that ZIKV infection augmented the death of fNSCs in the neurospheres, in proportion to their size ( Figure S1E ). While ZIKV infection did not alter the expression of neural stem cell markers, e.g., Nestin and SOX2 (Figures 1F and 1G) , it led to the progressive reduction of fNSC proliferation as reflected by BrdU incorporation ( Figure  S1F ). These results show that ZIKV infection not only induces the death of human fNSCs but also impairs their proliferation and clonal expansion in neurospheres.
The endoplasmic reticulum provides a membrane platform for the biogenesis of flavivirus replication complex, and autophagy-dependent processing of lipid droplets is required for efficient flavivirus replication (Heaton and Randall, 2010) . To determine changes in the level of autophagy upon ZIKV infection, we examined the light chain 3 (LC3)-I to LC3-II conversion and the formation of LC3 punctate structure in ZIKV-infected fNSCs. Infection with ZIKV strains MR766 and IbH30656 efficiently induced LC3-I to LC3-II conversion and LC3 puncta formation of fNSCs in the presence or absence of lysosome inhibitor bafilomycin A1 (Figures 1H-1I and S1G-S1I). The p62/SQSTM level also decreased due to ZIKV-mediated autophagosome maturation (Figures 1H and S1G) . Similar results were obtained from HeLa cells and MEFs (Figures S1J-S1L and S2A-S2D). To investigate the role of autophagy in ZIKV infection, we assessed ZIKV replication using Atg3 knockout (KO) MEFs, in which autophagy is completely defective due to the loss of the Atg3 E2 enzyme. ZIKV replication was reduced by approximately 7-fold in Atg3 KO MEFs compared to wild-type MEFs ( Figures S2E and S2F ). In addition, ZIKV-infected Atg3 KO MEFs showed no detectable LC3-I to LC3-II conversion ( Figure S1L ). Similar results were obtained in Atg5 KO MEFs, and Atg3 or Atg13 knockdown fNSCs ( Figures S2G-S2I) . Accordingly, the induction of autophagy by rapamycin promoted ZIKV load in both fNSCs and HeLa cells, whereas the inhibition of autophagy by 3-MA or chloroquine impaired ZIKV load ( Figures 1J, S2J , and S2K). These results indicate that ZIKV infection induces autophagy in fNSCs, which in turn leads to increased ZIKV replication and viral load.
ZIKV NS4A and NS4B Suppress Neurogenesis of Human fNSCs
Previous reports (Garcez et al., 2016; Qian et al., 2016) as well as our current study demonstrate that ZIKV infection impairs the growth and proliferation of iPSC-derived NSCs and fNSCs. Like other flavivirus family members, ZIKV is expected to encode ten viral proteins including three structural and seven non-structural proteins (NSs). To determine which viral proteins might play inhibitory roles in cell proliferation and neurosphere formation, human fNSCs were transduced with lentivirus containing each ZIKV gene and examined for neurosphere formation ( Figures S3A-S3C ). Expression of each ZIKV protein was detected by immunoblotting at 2 dpi ( Figure S3D ), and the size and number of neurospheres were measured at 7 dpi. Interestingly, human fNSCs expressing NS4A or NS4B exhibited impaired neurosphere formation (Figure 2A ), as reflected in their reduced efficiency of neurosphere production from standard aliquots of 1 × 10 5 fNSCs ( Figure 2B ). Moreover, the majority of neurospheres (>90%) were less than 100 μm in diameter ( Figure  2C ), and the average neurosphere size significantly reduced by 40.3% or 32.3%, respectively, when NS4A or NS4B was expressed ( Figure S3C ). Remarkably, co-expression of NS4A and NS4B resulted in further inhibition of neurosphere formation, with the near absence of neurospheres with diameters of 100 μm or higher and a reduction of average neurosphere size by 52.0% (Figures 2A-2C and S3A-S3C). Unlike ZIKV NS4A and NS4B, co-expression of DENV NS4A and NS4B did not cause the significant inhibition of neurosphere formation under the same conditions ( Figures S3E-S3G ).
BrdU incorporation analysis showed that expression of NS4A, NS4B, or NS4A-NS4B also altered the proliferation rates of fNSCs ( Figures 2D-2F ) without affecting the expression of fNSCs markers, including SOX2 (Figure 2A) . Specifically, the expression of NS4A, NS4B, or NS4A-NS4B led to a 48.9%, 44.1%, or 64.7% reduction of fNSC proliferation, respectively, compared to the vector control ( Figure 2D ). In addition, immunostaining for Nestin and Ki-67 showed that expression of NS4A, NS4B, or NS4A-NS4B led to a ~43%, ~28%, or ~63% reduction of Nestin + -and Ki-67 + -positive proliferating fNSCs, respectively, compared with that of vector control (Figures 2E and 2F) . More interestingly, when fNSCs were cultured on poly-L-ornithine-and laminin-coated surface for 10 days to induce their differentiation into neuronal cells (Guo et al., 2013; Wang et al., 2010) , fNSCs expressing NS4A, NS4B, or NS4A-NS4B poorly differentiated into neurons or astrocytes (Figures 2G-2J ). Upon expression of NS4A, NS4B, or NS4A-NS4B, the differentiation rates to the β3-tubulin-positive neuronal cells and GFAP-positive astrocytes were reduced by approximately 25%-54% and 28%-51%, respectively ( Figures 2H and 2J) . However, expression of NS4A, NS4B, or NS4A-NS4B did not lead to apoptotic cell death in fNSCs, suggesting that expression of NS4A and NS4B is not toxic to cells ( Figure S3H ). Collectively, these data demonstrate that mitotic neurogenesis of fNSCs is selectively and substantially impaired by ZIKV NS4A and NS4B when these proteins are ectopically expressed individually and in combination.
ZIKV NS4A and NS4B Induce Autophagy in Human fNSCs
Since ZIKV infection induces autophagy in multiple cell types, we attempted to determine which viral proteins trigger that process. Transient expression of individual ZIKV genes in HeLa-GFP-LC3 cells showed that the expression of either NS4A or NS4B had marginal effects on GFP-LC3 punctate formation, whereas the co-expression of both NS4A and NS4B led to a significant increase in GFP-LC3 punctate numbers per cell ( Figures 3A-3B and S4A-S4D). Furthermore, when fNSCs or HeLa cells stably expressing vector, NS4A, NS4B, or NS4A-NS4B were used, expression of NS4A-NS4B also resulted in a significant increase of LC3 I→II conversion in the presence or absence of lysosome inhibitor bafilomycin A1 ( Figures 3C-3F, S4E, and S4F ). In addition, NS4A interacted with NS4B in cells ( Figure S4H ), and the partial colocalizations between GFP-LC3 and NS4A or NS4B were also detected ( Figure S4G ). These results show that ZIKV NS4A and NS4B collaborate to induce efficient autophagy.
ZIKV NS4A and NS4B Inhibit Akt-mTOR Signaling
Akt-mTOR signaling is essential for neurogenesis by human fNSCs as well as for the induction of autophagy. Specifically, Akt phosphorylation at Thr308 and Ser473 is required for its full kinase activity (Chan et al., 2014) and subsequently, Akt-mediated mTOR phosphorylation at Ser2448 is essential for keeping autophagy in check. Our results show that ZIKV replication led to the suppression of Akt phosphorylation at both Thr308 and Ser473, which subsequently led to the reduction of mTOR phosphorylation at Ser2448 (Figures 4A and S4I ). Further screening of individual ZIKV protein revealed that expression of either NS4A or NS4B detectably reduced Akt phosphorylation at both Thr308 and Ser473 under normal conditions ( Figure 4B ). When starved fNSCs or HeLa cells stably expressing vector, NS4A, NS4B, or NS4A-NS4B were stimulated with serum or insulin, expression of either NS4A or NS4B detectably suppressed the Thr308 and Ser437 phosphorylations of Akt, and co-expression of NS4A and NS4B drastically suppressed the Thr308 and Ser473 phosphorylations of Akt (Figures 4C-4E) . Consequently, co-expression of NS4A and NS4B resulted in the reduced levels of mTOR phosphorylation at Ser2448 (Figures 4C-4E ). To confirm that the increased autophagy by NS4A-NS4B was caused by impaired Akt/mTOR signaling, we expressed the constitutively active form of Akt3 (myr-HA-Akt3 E17K) in fNSCs to examine whether it blocked ZIKV infection-or NS4A-NS4B-expression-mediated autophagy (Baek et al., 2015) . As shown in Figures S4J and S4K , ectopic expression of the constitutively active form of Akt3 suppressed ZIKV infection-or NS4A-NS4B-expressionmediated autophagy. These results suggest that ZIKV NS4A and NS4B inhibit the AktmTOR signaling pathway, which in turn impedes the neurogenesis of fNSCs and increases autophagy.
DISCUSSION
Recent ZIKV outbreaks in South and Central America and the unexpected association between ZIKV infection and birth defects have attracted global attention to the need to study the pathogenesis of ZIKV-associated microcephaly and to develop therapeutic interventions against it. Recent reports demonstrated that ZIKV infection impairs growth in iPSC-derived human neurospheres and brain organoids (Garcez et al., 2016; Qian et al., 2016) . Infection of different mouse models has revealed that ZIKV infection can cause neurological development anomalies in mice as well (Lazear et al., 2016; Li et al., 2016; Miner et al., 2016; Rossi et al., 2016 ). Yet to date, no detailed molecular mechanisms underlying ZIKV pathogenesis have been unveiled, hence hindering the development of ZIKV-targeted antiviral therapy. In this paper, we utilized NSCs isolated from human fetuses between 18 and 22 weeks of gestational age to study how ZIKV infection impairs growth and neurogenesis of fNSCs. By screening the three structural proteins and seven NSs of ZIKV, we found that the cooperation of NS4A and NS4B strongly suppresses host Akt-mTOR signaling, consequently leading to the impairment of neurogenesis of human fNSCs and the upregulation of autophagy for viral replication.
Autophagy is a lysosome-mediated catabolic process that also developed as an important ancient immune response during evolution. Although hosts have evolved autophagy to maintain cellular homeostasis and limited pathogen infection, some pathogens such as flaviviruses usurp cellular autophagy pathways to benefit their life cycles. ZIKV infection induces autophagy in multiple cell types including fNSCs. Our results demonstrate that the autophagy inducer rapamycin increases ZIKV replication, whereas the autophagy inhibitor 3-MA or chloroquine decreases ZIKV replication. Although these inducers or inhibitors also affect additional pathways besides autophagy, genetic KO or knockdown of several autophagy genes shows the specific suppression of ZIKV replication, suggesting that an efficient replication of ZIKV depends on the autophagy pathway. In fact, DENV replication requires autophagy to control processing of lipid droplets and triglycerides (Heaton and Randall, 2010) and HCV uses autophagosomal membranes as sites for its RNA replication (Sir et al., 2012) . Thus, these findings suggest that ZIKV may also require host autophagy pathways to create the membrane structures to serve as viral replication sites.
By screening the ten ZIKV-encoding potential proteins, we found that NS4A and NS4B cooperate to induce efficient autophagy by suppressing the Akt-mTOR signaling pathway that is essential for controlling stimulation-induced autophagy. Similar to DENV NS4A and NS4B, ZIKV NS4A and NS4B are small hydrophobic proteins with potential transmembrane spanning regions (Zou et al., 2015) . While DENV NS4A alone induces autophagy (McLean et al., 2011) , an individual expression of ZIKV NS4A or NS4B has weak effects on autophagy, suggesting that ZIKV utilizes different molecular mechanisms from DENV to induce autophagy. While expression of the constitutively active Akt fully suppressed either ZIKV infection-or NS4A-NS4B-expression-mediated autophagy, it is possible that the mechanism of ZIKV infection-mediated autophagy is not entirely identical to that of NS4A-NS4B-expression-mediated autophagy. Future studies with the reverse genetic analysis of ZIKV are needed to address how NS4A and NS4B target and inhibit Akt in the context of viral genome (Shan et al., 2016) .
The Akt-mTOR signaling pathway is critical not only for controlling autophagy induction, but also for cortical development (Franke, 2008) . Mutations in this pathway lead to several disorders, such as megalencephaly by the constitutive activation of Akt and microcephaly by the loss of function of Akt (Mirzaa et al., 2013) . Our data suggest that ZIKV NS4A and NS4B suppress the activation of Akt, consequently leading to the impairment of proliferation and differentiation of fNSCs in vitro. These may serve as a potential molecular mechanism by which ZIKV infection can lead to neurological disorders such as microcephaly. Due to its crucial role in cell growth and differentiation, Akt activity is tightly controlled by post-translational modifications. Phosphorylations on Thr308 by PDK1 and on Ser473 by mTORC2 are important for Akt activation, and phosphatases such as PTEN, PP2A, and PHLPP antagonize Akt activation. Other modifications such as ubiquitination, SUMOylation, acetylation, and O-GlcNAcylation have been also shown to positively or negatively regulate Akt activities (Chan et al., 2014) . Our study suggests that ZIKV NS4A and NS4B block Akt activation by inhibiting upstream PI3K signaling and potentially modulating Akt post-translational modifications as well. Further studies will be required to parse the specific means by which ZIKV NS4A and NS4B influence Akt activation.
It should be noted that we utilized primary fNSCs recovered from human fetuses to demonstrate how three ZIKV strains (MR766, IbH30656, and H/PF/2013) can impair the growth and neurogenesis of human fNSCs. Regardless of the viral strains and fNSC isolates, similar levels of neurogenesis inhibition and autophagy induction were observed. However, it is possible that the ongoing epidemic ZIKV strains in Brazil and other South American countries may cause more severe defects in the proliferation of fNSCs and subsequent differentiation during corticogenesis. On the other hand, since the sequences of NS4A and NS4B are almost identical across various ZIKV strains, additional factors might also be associated with pathogenesis of the ongoing epidemic ZIKV strains. Additional studies are ongoing to demonstrate the functions of NS4A and NS4B in in vitro brain organoid models and in vivo IFNAR1 KO mouse models. In summary, our research provides new mechanistic insights on how NS4A and NS4B phenocopy ZIKV pathogenesis in vitro, implicating them as potential anti-ZIKV therapeutic targets.
EXPERIMENTAL PROCEDURES
Viruses, Plasmids, and Cell Culture ZIKV strain MR766 (Uganda, 1947 ) and H/PF/2013 (French Polynesia, 2013 were kindly provided by Dr. Michael Diamond (Washington University School of Medicine) and Dr. Cécile Baronti (Aix Marseille Université). ZIKV strain IbH30656 was purchased from ATCC. ZIKV stocks were propagated in Vero cells or C6/36 Aedes albopictus cells after being inoculated at an MOI of 0.02 and supernatants were harvested at 96 hpi. The titers of ZIKV stocks were determined by plaque assay on Vero cells as described previously (Liang et al., 2014) .
ZIKV cDNA was synthesized as DNA fragments (IDT) and ZIKV expression constructs were amplified by PCR and cloned into lentiviral pCDH-puro or pCDH-Hyg vectors with the N-terminal Flag tag. All constructs were sequenced using an ABI PRISM 377 automatic DNA sequencer to verify 100% correspondence with the original sequence.
HeLa cells, HEK293T cells, and MEFs were maintained in DMEM (GIBCO-BRL) containing 4 mM glutamine and 10% FBS. Vero cells were cultured in DMEM with 5% FBS and 4 mM glutamine. C6/36 Aedes albopictus cells were cultured in DMEM with 10% FBS, non-essential amino acids, and HEPES at 28° with 5% CO 2 . Transient transfections were performed with Lipofectamine 2000 (Invitrogen). HeLa stable cell lines were generated using a standard selection protocol with puromycin (2 μg/mL) for individual expressions of ZIKV gene, or puromycin with hygromycin (200 μg/mL) for the co-expression of NS4A-NS4B.
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Highlights
• ZIKV infects human fNSCs, leading to defective neurogenesis and increased autophagy 
In Brief
Liang et al. show that after infection of human fetal neural stem cells, the ZIKV proteins NS4A and NS4B inhibit the Akt-mTOR signaling pathway, disrupting neurogenesis and inducing autophagy. Their study therefore identifies candidate molecular determinants of ZIKV pathogenesis and highlights potential targets for therapeutic intervention. (F and G) Representative confocal images showing 3D reconstruction of neurospheres at 7 dpi with MR766 or mock treatment. Nestin and SOX2 were used as fNSC-specific markers; ZIKV was immunostained against its E protein in (F); apoptotic cell death was marked by TUNEL staining in (G). Scale bar, 50 μm. (H) ZIKV infection induces autophagy in fNSCs. fNSCs were infected with ZIKV and LC3 processing was examined by immunoblot at indicated time points.
(I) fNSCs infected with ZIKV at MOI 0.1 were fixed and stained with indicated antibodies and LC3 puncta were counted. Mean ± SEM; p < 0.05 by one-way ANOVA.
(J) Autophagy is required for the efficient replication of ZIKV. fNSCs were infected with ZIKV MR766 at MOI 0.5, and the medium was changed with indicated drugs (rapamycin 50 nM, 3-MA 2 μM, chloroquine 5 μM) at 1 hpi. The mRNA levels of ZIKV were measured by RT-qPCR at 10 hpi. See also Figure S4 .
